Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...

Radiopharm Theranostic (RADX)s announced a poster presentation at EMIM 20251, with findings that support the clinical utility of imaging and ...

EsoBiotec’s Engineered NanoBody Lentiviral (ENaBL) platform speeds up gene modifications in immune ... AstraZeneca’s CEO, Pascal Soriot, has stressed the need to adopt new treatments like ...